C-Matrix designed and executed TESARO’s Swiss launch event, leveraging its extensive media, political, and business networks to secure high attendance and significant media coverage. The event featured VIP speakers, including the local Finance Minister and the Deputy US Ambassador, and was meticulously coordinated—from bilingual invitations to post-event follow-up. This strategic approach strengthened TESARO’s brand visibility and credibility among key Swiss decision-makers, ultimately contributing to its acquisition by GlaxoSmithKline.
Key Objectives
To establish TESARO’s Swiss market entry as a high-impact event, building trust in its products among influential business and government stakeholders. By securing prominent speakers, targeted media engagement, and seamless event execution, C-Matrix aimed to position TESARO as a leader in ovarian cancer treatment innovation.
Approach
- VIP Guest List & Invitations: Curated a high-profile guest list and sent bilingual invitations to ensure participation from key political and economic leaders.
- Keynote Speakers: Secured the local Finance Minister and Deputy US Ambassador as speakers to underscore the event’s significance.
- Media Outreach: Prepared a national press release and organised an exclusive CEO interview to maximise media exposure.
- Moderation & Coordination: Developed discussion guides, key messages, and served as master of ceremonies to ensure a cohesive program.
- Logistics & Follow-Up: Oversaw on-site logistics and post-event engagement to sustain momentum and impact.
Result
The event achieved outstanding success: widespread media coverage in top business and regional outlets, enthusiastic guest feedback, and a marked boost in TESARO’s brand reputation. This strategic positioning played a pivotal role in TESARO’s subsequent acquisition by GlaxoSmithKline, validating the campaign’s effectiveness.
Interested in an effective communication strategy? Contact us to arrange an initial call.
+41 43 300 56 56